Close Menu

NEW YORK (GenomeWeb) – NovellusDx announced today that it has raised $6 million in equity financing.

Helsinn Investment Fund SA SICAR, BioCapital Impact Fund, and Windham Venture Partners all participated in the funding round. The company said it had also previously raised nearly $17 million.

In a statement, NovellusDx CEO Haim Gil-Ad said the funding will allow the firm to commercialize and support continuing development and improvement of its next-generation sequencing technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Researchers turn to protein analysis to examine an ancient rhino sample, reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.